ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PUMD ProUroCare Medical Inc (CE)

0.0001
0.00 (0.00%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ProUroCare Medical Inc (CE) USOTC:PUMD OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.00 01:00:00

Statement of Changes in Beneficial Ownership (4)

04/02/2014 7:44pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Shuler Alan
2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Interim CFO
(Last)          (First)          (Middle)

6440 FLYING CLOUD DRIVE, SUITE 101
3. Date of Earliest Transaction (MM/DD/YYYY)

1/31/2014
(Street)

EDEN PRAIRIE, MN 55344
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   1/31/2014     A    23987   (1) A $0   189858   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrant (right to buy)   $.50                    10/31/2013   10/1/2016   Common Stock   75000     75000   D    
10% Convertible Promissory Note   $.50   (2)                  10/31/2013   (3) 10/1/2015   Common Stock   $25000   (4)   $25000   (4) D    

Explanation of Responses:
( 1)  Represents shares received are in lieu of cash fees under a consulting agreement between the reporting person and the issuer.
( 2)  Subject to adjustment based on a predefined formula set forth in the 10% Secured Convertible Note.
( 3)  On October 31, 2013, the reporting person purchased $25,000, 10% secured convertible promissory note from the issuer in a private placement. The promissory note matures on October 1, 2015, however, the holders have an optional conversion at any time prior to maturity at an exercise price predetermined by a formula set forth in the promissory note.
( 4)  The number of underlying common shares of the issuer will determined at the time of conversion based on a predefined formula set forth in the promissory note.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Shuler Alan
6440 FLYING CLOUD DRIVE
SUITE 101
EDEN PRAIRIE, MN 55344


Interim CFO

Signatures
/s/ Alan Shuler 2/4/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year ProUroCare Medical (CE) Chart

1 Year ProUroCare Medical (CE) Chart

1 Month ProUroCare Medical (CE) Chart

1 Month ProUroCare Medical (CE) Chart